IL-17 T cells' defective differentiation in vitro despite normal range ex vivo in chronic mucocutaneous candidiasis due to STAT1 mutation.
IL-17 T cells' defective differentiation in vitro despite normal range ex vivo in chronic mucocutaneous candidiasis due to STAT1 mutation.
复制标题
DOI:
10.1038/jid.2013.480
复制
发表时间:
2014-04
期刊:
影响因子:
--
通讯作者:
N. Mekki;I. Ben‐Mustapha;Luyan Liu;L. Boussofara;S. Okada;Sophie Cypowyj;N. Ghariani;W. Saidi;M. Denguezli;J. Casanova;A. Puel;M. Barbouche
中科院分区:
文献类型:
--
作者:
N. Mekki;I. Ben‐Mustapha;Luyan Liu;L. Boussofara;S. Okada;Sophie Cypowyj;N. Ghariani;W. Saidi;M. Denguezli;J. Casanova;A. Puel;M. Barbouche
Chronic mucocutaneous candidiasis disease (CMCD), first described clinically in 1969, is characterized by recurrent or persistent infections of the skin and mucosae with Candida albicans with no or a few other clinical manifestations (Kirkpatrick, 2001; Lilic, 2002). In 2011, Puel et al.(2011) identified the first inborn errors of IL-17 immunity underlying CMCD: complete autosomal-recessive IL-17RA and partial autosomal-dominant(AD) IL-17F deficiencies. AD CMCD has since been shown to be caused by heterozygous mutations in the coiled-coil domain of the STAT1 gene (Liu et al., 2011; Smeekens et al., 2011; van de